This opportunity is no longer accepting applications.
grant PAR-21-138

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)

The National Cancer Institute (NCI) offers the MERIT (R37) Award to provide extended grant support specifically for Early Stage Investigators (ESIs). This grant aims to give ESIs more time and flexibility to foster creativity and innovation, helping them to establish their careers without the immediate need to submit renewal applications. The award allows eligible investigators to receive up t…

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: June 7, 2021
Open for Submission: June 3, 2021
Submission Deadline: December 1, 2024
Application Window Closes: December 1, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.